FY ended March 2019

• Japan: Sales increased 1.6%. In order to respond to market changes such as the government’s healthcare reforms, the Company put more sales resources into the Tokyo metropolitan area in April 2018, following the absorption of 11 domestic sales subsidiaries in April 2017. Sales increased as the Company enhanced sales activities which match each market; the acute care hospital market, the small and mid-sized hospital market, and the clinic market. Consumables and services also contributed to the sales increase. Sales of AEDs in the PAD market increased favorably and sales in the public hospital market also increased as the Company received orders related to replacement of diagnostic information systems and clinical information systems. Sales in the university and private hospital market remained flat, while sales in the clinic market decreased as sales of locally purchased products decreased in accordance with the Company's initiative to expand in-house products sales.
• International: Sales increased 5.4%. Sales of Physiological Measuring Equipment and Patient Monitors increased favorably. Sales of Treatment Equipment also increased, while sales of Other Medical Equipment decreased.

• Americas: Sales increased 6.9%. Sales in the U.S. increased favorably as the Company expanded its patient monitoring business and reorganized the sales structure of EEGs. Sales in Latin America decreased due to weak sales in Chile and Colombia, offsetting strong sales in Brazil and Mexico. 
• Europe: Sales decreased 3.5% as sales in Russia and Turkey decreased, although sales in France and U.K. increased. 
• Asia: Sales increased 10.7%. Sales increased, especially in China and Thailand. Sales recovery in India and large orders in Qatar also contributed to the sales increase.
• Other: Sales decreased 10.3% due to weak performance in Africa such as Ethiopia.